Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications

Project Information

P70-IMMUNEBREAST

Grant agreement ID: 893597

DOI 10.3030/893597

Project closed

EC signature date 30 April 2020

Start date 1 January 2021

End date 5 March 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 160 932,48

EU contribution € 160 932,48

Coordinated by

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Spain

Publications

Peer reviewed articles (1)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.

Author(s): Rebeca Jimeno; Silvana Mouron; Roberto Salgado; Sherene Loi; Belén Pérez-Mies; Rodrigo Sánchez-Bayona; Luis Manso; Mario Martínez; Ana Garrido-García; Rosario Serrano-Pardo; Ramón Colomer; Miguel Quintela-Fandino
Published in: Clinical and Translational Oncology, Issue Dec 2022, 2022, ISSN 1699-048X
Publisher: Doyma
DOI: 10.1007/s12094-022-03006-3